XML 26 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
$ in Thousands
Total
Total Equity Attributable to Common Stockholders
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2022     205,664,690        
Beginning balance at Dec. 31, 2022 $ 378,816 $ 340,777 $ 20 $ 3,906,491 $ (1,251) $ (3,564,483) $ 38,039
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of restricted stock awards (in shares)     2,104,904        
ESPP purchase (in shares)     449,525        
ESPP purchase 7,756 7,756   7,756      
Exercise of stock options (in shares)     114,526        
Exercise of stock options 769 769   769      
Stock-based compensation 29,294 29,294   29,294      
Derecognition of the pre-modified forward contract fair value 76,242 76,242   76,242      
Equity component of redeemable convertible preferred stock 16,145 16,145   16,145      
Foreign currency translation adjustment (271) (101)     (101)   (170)
Net (loss) income (74,917) (71,567)       (71,567) (3,350)
Ending balance (in shares) at Mar. 31, 2023     208,333,645        
Ending balance at Mar. 31, 2023 433,834 399,315 $ 20 4,036,697 (1,352) (3,636,050) 34,519
Beginning balance (in shares) at Dec. 31, 2023     224,717,533        
Beginning balance at Dec. 31, 2023 520,670 502,078 $ 21 4,370,343 (1,687) (3,866,599) 18,592
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of restricted stock awards (in shares)     1,483,902        
ESPP purchase (in shares)     632,688        
ESPP purchase 6,297 6,297   6,297      
Exercise of stock options (in shares)     99,640        
Exercise of stock options 519 519   519      
Stock-based compensation 16,989 16,989   16,989      
Contributions from noncontrolling interest 3,958           3,958
Accrued dividend (1,620) (1,620)       (1,620)  
Legal reserve 147 147       147  
Subsidiary liquidation (319) (319)       (319)  
Foreign currency translation adjustment (948) (452)     (452)   (496)
Net (loss) income (56,543) (57,524)       (57,524) 981
Ending balance (in shares) at Mar. 31, 2024     226,933,763        
Ending balance at Mar. 31, 2024 $ 489,150 $ 466,115 $ 21 $ 4,394,148 $ (2,139) $ (3,925,915) $ 23,035